Treating COVID-19 with Chloroquine

J Mol Cell Biol. 2020 May 18;12(4):322-325. doi: 10.1093/jmcb/mjaa014.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Betacoronavirus / physiology
  • Chloroquine / adverse effects
  • Chloroquine / therapeutic use*
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / immunology
  • Drug Combinations
  • Humans
  • Lopinavir / adverse effects
  • Lopinavir / therapeutic use
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / immunology
  • Ritonavir / adverse effects
  • Ritonavir / therapeutic use

Substances

  • Drug Combinations
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • Chloroquine
  • Ritonavir

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2